Table 2.
CYPA(+) | EBV(+) | EBV(‐) | ||
---|---|---|---|---|
Sera | Serum EXO | Sera | Serum EXO | |
NPC | 84.0% (63/75) | 78.7% (59/75) | 91.4% (32/35) | 80.0% (28/35) |
NC | 0 | 0 | 47.2% (17/36) | 16.7% (6/36) |
CYPA, cyclophilin A; EBV, Epstein‐Barr virus; EXO, exosomes; NC, normal cases; NPC, nasopharyngeal carcinoma.